Dermatomyositis, characterized by muscle weakness and skin symptoms, is a condition linked to increased morbidity and mortality. It markedly affects the quality of life for individuals afflicted, as well as the well-being of their families. According to DelveInsight’s estimates, in 2023, there were nearly 72K diagnosed prevalent cases of dermatomyositis in the seven major markets (the US, Germany, France, Italy, Spain, the UK, and Japan), with approximately 91% of cases occurring in adults and 9% in juveniles.
Understanding the Disease
Dermatomyositis is a rare autoimmune disorder associated with muscle inflammation (myositis) and skin inflammation (dermatitis)...
